On Tuesday, November 12th, students at the University of Wisconsin received an email from the Raison Lab asking if they were interested in a lab studying the effect of psilocybin. The study offered up ...

A direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional ...

"Magic" mushrooms achieve their psychedelic effects by temporarily scrambling a brain network involved in introspective thinking like daydreaming and remembering, a new study reports. Brain scans of ...

A new study shows that the use of psilocybin, a compound found in the widely known "magic mushrooms," initiates a pattern of hyperconnectivity in the brain linked to the ego-modifying effects and ...

People in a new study who took psilocybin often experienced headache, nausea, anxiety, dizziness and elevated blood pressure -- side effects similar to those seen with regular antidepressants. Photo ...

Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ...

That project, which the Food and Drug Administration has greenlit, exemplifies a renaissance of research investigating the psychotherapeutic potential of a drug that has been federally prohibited ...

Many people with tough-to-treat depression may be trying psilocybin, the active ingredient in magic mushrooms, as an alternative to antidepressants. Thinking that it's a "natural" drug, folks might ...

A new study published in Progress in Neuropsychopharmacology & Biological Psychiatry has found that a single moderate dose of psilocybin produces rapid and lasting antidepressant-like effects in rats, ...